Market Cap 2.62B
Revenue (ttm) 605.49M
Net Income (ttm) 190.29M
EPS (ttm) N/A
PE Ratio 29.07
Forward PE 37.06
Profit Margin 31.43%
Debt to Equity Ratio 0.12
Volume 317,554
Avg Vol 1,447,892
Day's Range N/A - N/A
Shares Out 34.56M
Stochastic %K 74%
Beta 1.89
Analysts Strong Sell
Price Target $110.70

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 552 0900
Address:
200 Minuteman Road, Suite 302, Andover, United States
AlphaBreastPlate
AlphaBreastPlate Jul. 15 at 5:53 PM
$TMDX tutes want this right at $75 to kill options this Friday.
0 · Reply
AlphaBreastPlate
AlphaBreastPlate Jul. 15 at 12:07 AM
$TMDX I guess the fleet is done repositioning?
0 · Reply
EquityVoyager_1
EquityVoyager_1 Jul. 14 at 6:51 PM
The market is punishing $TMDX, but is it missing the bigger picture? $TMDX CEO buying ~$2M$3M of shares should signal confidence, yet the stock has dropped about 34% since the insider purchase. Key points: $TMDX has historically never traded below ~4x forward revenue. Growth remains strong, with FY26 revenue expected to grow around 22% before Europe and kidney expansion fully contribute. Short-term margin pressure matters less when management is building for a 3–5 year horizon. 2030 goal: 20,000 transplants vs 5,139 in FY25 - a potential 31%+ CAGR in procedure volume. The stock has been painful short term, but long-term investors may see today’s weakness differently.
0 · Reply
KabX
KabX Jul. 14 at 4:32 PM
$TMDX Crazy we still only have under 7k people following this on ST lol
1 · Reply
BringTheBrinks
BringTheBrinks Jul. 14 at 1:23 PM
$TMDX Buy now. Once $80 breaks, enormous gap up to $95.
1 · Reply
Jonnybegood2
Jonnybegood2 Jul. 14 at 10:37 AM
$TMDX bullish
0 · Reply
EdTex
EdTex Jul. 14 at 12:44 AM
$TMDX Showing some life, nice.
0 · Reply
k3vl4r
k3vl4r Jul. 13 at 9:01 PM
Tough day out there. Not a great win rate from our platforms top picks but, its green. $TMDX $MORN $NCNO 1 day · win rate 41.9% — full public track record (wins & misses): https://app.k3vl4r.com/track-record?utm_source=member_share&utm_medium=weekly_card&utm_campaign=weekly_picks The Day's Corners; Where the opportunities were: https://app.k3vl4r.com/blog/the-day-s-corners-where-the-opportunities-were-222
0 · Reply
sellthetop
sellthetop Jul. 13 at 8:17 PM
$TMDX so obvious its going back to 100
0 · Reply
mexmanTV
mexmanTV Jul. 13 at 7:16 PM
0 · Reply
Latest News on TMDX
TransMedics rises 8.0%

2026-07-13T16:05:40.000Z - 2 days ago

TransMedics rises 8.0%


TransMedics completes strategic investment in PAD Aviation

2026-07-06T11:15:54.000Z - 9 days ago

TransMedics completes strategic investment in PAD Aviation


TransMedics price target raised to $80 from $75 at Stifel

2026-06-18T10:42:30.000Z - 27 days ago

TransMedics price target raised to $80 from $75 at Stifel


TransMedics price target lowered to $75 from $85 at Stifel

2026-05-26T10:54:01.000Z - 7 weeks ago

TransMedics price target lowered to $75 from $85 at Stifel


TransMedics Group Proxy statement: Proxy filing

May 7, 2026, 8:00 AM EDT - 2 months ago

TransMedics Group Proxy statement: Proxy filing


TransMedics price target lowered to $140 from $157 at Baird

2026-05-07T09:04:08.000Z - 2 months ago

TransMedics price target lowered to $140 from $157 at Baird


TransMedics price target lowered to $85 from $130 at Stifel

2026-05-07T07:51:01.000Z - 2 months ago

TransMedics price target lowered to $85 from $130 at Stifel


TransMedics price target lowered to $124 from $152 at Canaccord

2026-05-07T06:59:58.000Z - 2 months ago

TransMedics price target lowered to $124 from $152 at Canaccord


TransMedics price target lowered to $120 from $190 at TD Cowen

2026-05-07T05:04:44.000Z - 2 months ago

TransMedics price target lowered to $120 from $190 at TD Cowen


TransMedics price target lowered to $142 from $174 at Needham

2026-05-07T03:53:35.000Z - 2 months ago

TransMedics price target lowered to $142 from $174 at Needham


TransMedics falls -20.5%

2026-05-07T03:40:51.000Z - 2 months ago

TransMedics falls -20.5%


TransMedics Group Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

TransMedics Group Earnings Call Transcript: Q1 2026


TransMedics Group Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

TransMedics Group Earnings release: Q1 2026


TransMedics Group Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

TransMedics Group Quarterly report: Q1 2026


TransMedics Group Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

TransMedics Group Slides: Q1 2026


TransMedics Reports First Quarter 2026 Financial Results

May 5, 2026, 4:05 PM EDT - 2 months ago

TransMedics Reports First Quarter 2026 Financial Results


TransMedics signs agreement to invest in PAD Aviation

2026-04-29T16:43:22.000Z - 2 months ago

TransMedics signs agreement to invest in PAD Aviation


TransMedics Group Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

TransMedics Group Proxy statement: Proxy filing


TransMedics Group Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

TransMedics Group Proxy statement: Proxy filing


TransMedics Group Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

TransMedics Group Earnings Call Transcript: Q4 2025


TransMedics Group Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

TransMedics Group Annual report: Q4 2025


TransMedics Group Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

TransMedics Group Earnings release: Q4 2025


TransMedics Group Slides: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

TransMedics Group Slides: Q4 2025


TransMedics to Present at Upcoming March Investor Conferences

Feb 17, 2026, 4:05 PM EST - 5 months ago

TransMedics to Present at Upcoming March Investor Conferences


TransMedics Group Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 9 months ago

TransMedics Group Earnings Call Transcript: Q3 2025


TransMedics Group Quarterly report: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 9 months ago

TransMedics Group Quarterly report: Q3 2025


TransMedics Group Earnings release: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 9 months ago

TransMedics Group Earnings release: Q3 2025


TransMedics Group Slides: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 9 months ago

TransMedics Group Slides: Q3 2025


TransMedics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 4:05 PM EDT - 9 months ago

TransMedics Reports Third Quarter 2025 Financial Results


TransMedics to Present at Upcoming September Investor Conferences

Aug 25, 2025, 4:05 PM EDT - 11 months ago

TransMedics to Present at Upcoming September Investor Conferences


TransMedics Group Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings Call Transcript: Q2 2025


TransMedics Group Quarterly report: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Quarterly report: Q2 2025


TransMedics Group Earnings release: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings release: Q2 2025


TransMedics Group Slides: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Slides: Q2 2025


TransMedics Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 1 year ago

TransMedics Reports Second Quarter 2025 Financial Results


TransMedics to Present at Upcoming June Investor Conferences

May 20, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Present at Upcoming June Investor Conferences


TransMedics Group Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings Call Transcript: Q1 2025


TransMedics Group Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Quarterly report: Q1 2025


TransMedics Group Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings release: Q1 2025


TransMedics Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 1 year ago

TransMedics Reports First Quarter 2025 Financial Results


AlphaBreastPlate
AlphaBreastPlate Jul. 15 at 5:53 PM
$TMDX tutes want this right at $75 to kill options this Friday.
0 · Reply
AlphaBreastPlate
AlphaBreastPlate Jul. 15 at 12:07 AM
$TMDX I guess the fleet is done repositioning?
0 · Reply
EquityVoyager_1
EquityVoyager_1 Jul. 14 at 6:51 PM
The market is punishing $TMDX, but is it missing the bigger picture? $TMDX CEO buying ~$2M$3M of shares should signal confidence, yet the stock has dropped about 34% since the insider purchase. Key points: $TMDX has historically never traded below ~4x forward revenue. Growth remains strong, with FY26 revenue expected to grow around 22% before Europe and kidney expansion fully contribute. Short-term margin pressure matters less when management is building for a 3–5 year horizon. 2030 goal: 20,000 transplants vs 5,139 in FY25 - a potential 31%+ CAGR in procedure volume. The stock has been painful short term, but long-term investors may see today’s weakness differently.
0 · Reply
KabX
KabX Jul. 14 at 4:32 PM
$TMDX Crazy we still only have under 7k people following this on ST lol
1 · Reply
BringTheBrinks
BringTheBrinks Jul. 14 at 1:23 PM
$TMDX Buy now. Once $80 breaks, enormous gap up to $95.
1 · Reply
Jonnybegood2
Jonnybegood2 Jul. 14 at 10:37 AM
$TMDX bullish
0 · Reply
EdTex
EdTex Jul. 14 at 12:44 AM
$TMDX Showing some life, nice.
0 · Reply
k3vl4r
k3vl4r Jul. 13 at 9:01 PM
Tough day out there. Not a great win rate from our platforms top picks but, its green. $TMDX $MORN $NCNO 1 day · win rate 41.9% — full public track record (wins & misses): https://app.k3vl4r.com/track-record?utm_source=member_share&utm_medium=weekly_card&utm_campaign=weekly_picks The Day's Corners; Where the opportunities were: https://app.k3vl4r.com/blog/the-day-s-corners-where-the-opportunities-were-222
0 · Reply
sellthetop
sellthetop Jul. 13 at 8:17 PM
$TMDX so obvious its going back to 100
0 · Reply
mexmanTV
mexmanTV Jul. 13 at 7:16 PM
0 · Reply
HyperbolicHedge
HyperbolicHedge Jul. 13 at 3:28 PM
$TMDX is off to a strong start, with flight activity data pointing to continued operational momentum. The market is still focused on whether growth can remain durable after the recent volatility. If management confirms that procedure growth, utilization, and expansion trends are holding, the setup could become increasingly interesting. At this stage, the key is not the daily move, but whether the underlying business trajectory remains intact.
0 · Reply
belsimtaq7
belsimtaq7 Jul. 13 at 3:02 PM
$TMDX Nice, now grind into the gap until ER and hopefully management delivers better results and outlook than the previous Q. Tough to get worse than that anyway.
0 · Reply
ripster47
ripster47 Jul. 13 at 3:01 PM
$TMDX 🚀❤️ $TMDX saving accounts today while AI names in swing port took hit
0 · Reply
PrudenceB0126
PrudenceB0126 Jul. 12 at 10:34 PM
$TMDX is absolutely crushing it. Over the past 11.7 days, the company completed 435 flights, or roughly 37 flights per day, an ~11% increase MoM. If it maintains this pace throughout Q3, $TMDX would complete approximately 3,404 flights during the quarter. That would translate to roughly 20% QoQ growth and 64% YoY growth. Those would be phenomenal numbers. If this trajectory continues, a guidance raise will most likely occur, along with a significant beat on FY2026 revenue guidance. In other words, $TMDX could have a strong rebound by the end of the year.
0 · Reply
PacAttackInc
PacAttackInc Jul. 12 at 7:51 PM
$TMDX Europe expansion. Anyone know yet what they actually invested to pull this off? https://www.thenew.money/article/transmedics-invests-in-german-aviation-company
1 · Reply
wolfstock91130
wolfstock91130 Jul. 12 at 2:40 PM
$TMDX Dry runs up 74% YoY sounds extreme, but if they stay the same share of total flights, the growth should scale with overall volume. That’s the key point here: not a weird mix shift, just proportional expansion in the underlying flight base.
1 · Reply
KabX
KabX Jul. 12 at 4:04 AM
0 · Reply
Lambster2
Lambster2 Jul. 11 at 11:54 PM
$TMDX TransMedics (NASDAQ: TMDX) Buy (1) Price Target: $120.00 Scaling the Next Phase: TMDX Positioning for Future Growth/Global Expansion THE TD COWEN INSIGHT Whether through expansion of international logistics capabilities or advancement of next-gen OCS platforms, TMDX is focused on constructing the operational foundation necessary to support substantially larger transplant volumes over the coming decade. Although near-term profitability is taking a step down, TMDX is becoming better positioned to capitalize on major TAM expansion opportunities.
2 · Reply
AlphaBreastPlate
AlphaBreastPlate Jul. 10 at 5:37 PM
$TMDX it’s clear the tutes who control the price action/volume on this stock do no believe the flight numbers. This ER is going to be truly amazing!! Remember, waheed said flight tracker is BS.
2 · Reply
WeeklyOptionsTrading
WeeklyOptionsTrading Jul. 10 at 4:43 PM
$TMDX I wanna buy more under 70
0 · Reply
AlphaBreastPlate
AlphaBreastPlate Jul. 10 at 3:09 PM
$TMDX @FreeRealityReal you get it yet? That $70 pegged. Been telling you. No quick buck here.
1 · Reply
k3vl4r
k3vl4r Jul. 9 at 11:25 PM
Just checked the charts and $TMDX is looking like the cleanest setup today. Strong fundamentals, oversold on higher timeframes, and every… Full pick, targets & ranked shortlist: https://app.k3vl4r.com/tp/tmdx-top-pick-swing-setup-31392b2c788a813baa8bf60df83e580b?utm_source=x&utm_medium=social&utm_campaign=top_pick&utm_content=TMDX #stocks #StockMarket
0 · Reply